462 related articles for article (PubMed ID: 26718155)
1. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in autosomal-dominant polycystic kidney disease.
Rangan GK; Tchan MC; Tong A; Wong AT; Nankivell BJ
Intern Med J; 2016 Aug; 46(8):883-92. PubMed ID: 27553994
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
[TBL] [Abstract][Full Text] [Related]
4. A polycystin-centric view of cyst formation and disease: the polycystins revisited.
Ong AC; Harris PC
Kidney Int; 2015 Oct; 88(4):699-710. PubMed ID: 26200945
[TBL] [Abstract][Full Text] [Related]
5. Molecular advances in autosomal dominant polycystic kidney disease.
Gallagher AR; Germino GG; Somlo S
Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
[TBL] [Abstract][Full Text] [Related]
6. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
Xu Y; Li A; Wu G; Liang C
Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
Saigusa T; Bell PD
Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
[TBL] [Abstract][Full Text] [Related]
8. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
Noël N; Rieu P
Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
[TBL] [Abstract][Full Text] [Related]
11. Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.
Cornec-Le Gall E; Audrézet MP; Le Meur Y; Chen JM; Férec C
Hum Mutat; 2014 Dec; 35(12):1393-406. PubMed ID: 25263802
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach in autosomal dominant polycystic kidney disease.
Pei Y
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.
Mochizuki T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2013 Jun; 17(3):317-26. PubMed ID: 23192769
[TBL] [Abstract][Full Text] [Related]
14. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
[TBL] [Abstract][Full Text] [Related]
16. Advances in autosomal dominant polycystic kidney disease-2014 and beyond.
Braun WE
Cleve Clin J Med; 2014 Sep; 81(9):545-56. PubMed ID: 25183846
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
Cai Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
Bastos AP; Onuchic LF
Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation, protein kinases and ADPKD.
Li X
Biochim Biophys Acta; 2011 Oct; 1812(10):1219-24. PubMed ID: 21392577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]